Medicine Safety
When it comes to medicines, safety has many meanings and many stakeholders: Volunteers in clinical trials, researchers and technicians working in laboratories and manufacturing facilities, regulators at the Food and Drug Administration (FDA), physicians prescribing medicines, and patients who rely on those therapies to lead healthier, longer lives—all have vested interests in drug safety. The safety and integrity of medicines is critical to America’s biopharmaceutical industry and the patients we serve. Learn more about the key medical safety issues facing our industry today.
For a Healthier U.S.: Methods to Fight Prescription Abuse
80% of counterfeit drugs are produced overseas
Latest From The Blog
blog url
Hospitals are hiding information that could lower costs for patients
September 24, 2026
ICYMI: Pennsylvania shows what biopharmaceutical innovation can deliver
September 21, 2026
New poll: 2 in 3 voters prefer a candidate committed to lowering health insurance premiums
September 18, 2026
Why PDUFA VIII keeps patients first and strengthens America's biopharma leadership
September 15, 2026
As football season kicks off, hospitals keep scoring on 340B
September 9, 2026
Bayh-Dole: The fuel for America’s innovation engine
September 2, 2026
ICYMI: Hospital consolidation is driving up health care costs
August 27, 2026
From lab to medicine cabinet: Following a medicine’s path to patients
August 24, 2026
What AARP isn’t telling seniors about MFN
August 24, 2026